HIGHLIGHTS
- who: Frontiers Production Office from the Media SA, Switzerland have published the Article: Erratum: Assessment of plasma Catestatin in COVID-19 reveals a hitherto unknown inflammatory activity with impact on morbidity-mortality, in the Journal: (JOURNAL)
SUMMARY
Innate immunity, COVID, Catestatin, Chromogranin A, hypoxia, critically ill, nosocomial disease An Erratum on: Assessment of plasma Catestatin in COVID-19 reveals a hitherto unknown inflammatory activity with impact on morbidity-mortality. Study participants (n=100) were screened for participation during the first surge of the disease (March to May 2020) among 547 patients admitted for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.